Skip to main content

Peer Review reports

From: Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Original Submission
25 Aug 2018 Submitted Original manuscript
9 Sep 2018 Author responded Author comments - Ye Jiang
Resubmission - Version 2
9 Sep 2018 Submitted Manuscript version 2
20 Oct 2018 Author responded Author comments - Ye Jiang
1 Oct 2018 Reviewed Reviewer Report - Joaquim Bosch
2 Oct 2018 Reviewed Reviewer Report - Marta Simó
Resubmission - Version 3
20 Oct 2018 Submitted Manuscript version 3
23 Oct 2018 Reviewed Reviewer Report - Joaquim Bosch
23 Oct 2018 Reviewed Reviewer Report - Marta Simó
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
31 Oct 2018 Editorially accepted
20 Nov 2018 Article published 10.1186/s12890-018-0734-1

You can find further information about peer review here.

Back to article page